For more than 200 years, biomedicine has approached the treatment of disease by studying disease processes (pathogenesis), inferring causal connections and developing specific approaches for therapeutically interfering with those processes. This pathogenic approach has been highly successful in acute and traumatic disease but less successful in chronic disease, primarily because of the complex, multifactorial nature of most chronic disease, which does not allow for simple causal inference or for simple therapeutic interventions. This article suggests that chronic disease is best approached by enhancing healing processes (salutogenesis) as a whole system. Because of the nature of complex systems in chronic disease, an evaluation model based on integrative medicine is felt to be more appropriate than a disease model. The authors propose and describe an integrated model for the evaluation of healing (IMEH) that collects multilevel "thick case" observational data in assessing complex practices for chronic disease. If successful, this approach could become a blueprint for studying healing capacity in whole medical systems, including complementary medicine, traditional medicine, and conventional primary care. In addition, streamlining data collection and applying rapid informatics management might allow for such data to be used in guiding clinical practice. The IMEH involves collection, integration, and potentially feedback of relevant variables in the following areas: (1) sociocultural, (2) psychological and behavioral, (3) clinical (diagnosis based), and (4) biological. Evaluation and integration of these components would involve specialized research teams that feed their data into a single data management and information analysis center. These data can then be subjected to descriptive and pathway analysis providing "bench and bedside" information.
Healing is defined as the process of recovery, repair, and reintegration that persons and biological systems continually invoke to establish and maintain homeostasis and function. These inherent processes are, by far, the most powerful components we have for recovery from illness and the maintenance of well-being.
The inherent capacity for healing in whole systems is more powerful for affecting illness (the symptoms and suffering that accompany physical disease) than disease-specific approaches alone, because diseasespecific approaches do not aim to treat illness but aim to treat disease. Healing approaches can but do not necessarily result in disease cure because their aim is not the elimination of the disease. The integration of lifestyle and complementary and alternative medicine (CAM) approaches with biomedicine is integral to accomplishing healing in health care. We borrow the term "salutogenesis" (the process of healing) from Antonovsky. 1 However, we use it here in a different way than he did in order to label this approach to health care by contrasting it with pathogenesis (the process of disease), the basis of the current disease-specific approaches in biomedicine.
The Healing Model in Health Care
Curative models in biomedicine seek to identify direct, models of disease etiology. They assume linear, causal pathways and require the discovery of direct etiological links to disease and then therapies that eliminate or interfere with those links. This is the model of pathogenesis developed and applied for the past 200 years. The pathogenic model is the main thrust of most biomedical research today and has resulted in a proliferation of subspecialized professions and acute care technologies. An alternative to this model is the healing model (salutogenesis). Healing models do not require specific or direct causal links to disease because they target inherent adaptogenic responses and assume that multilevel redundancies (multiple pathways) are characteristics of healing processes in every system. 2 We know from placebo and behavioral medicine research, for example, that manipulation of the social and cultural context, practitioner-patient-family communication strategies, the physical environment, and feedback of information in the health encounter can markedly change outcomes, often to a much greater extent than specific drug and even surgical treatments. 3, 4 In addition, science is providing us with detailed knowledge about the biological processes involved in healing and technology is allowing us to monitor those processes and adjust our interventions in real time. 5 These models lend themselves to the study and application of so-called nonspecific or multi-impact interventions that optimize function as a means of prevention and treatment of chronic diseases. Healing models describe a living organism as a nonlinear complex system that achieves optimal functioning autopoetically and that can react to small stimuli by nonlinear amplification provided that these stimuli trigger a cascade of reactions toward a stronger coherence of the system. These models form the basic framework for lifestyle-based and CAM systems that lend themselves to integration with biomedicine. Thus, a healing model is an appropriate focus of cross-disciplinary research teams for developing a science for generalist medicine. This has now been recognized in several disciplines. [6] [7] [8] [9] [10] Complementary and alternative medical systems often take a holistic approach, and so integrating them into health care provides an opportunity to develop research and evaluation approaches that are compatible with this whole systems framework.
Role of Integrative Medicine
Integrative medicine (IM) systems are defined as health care systems that integrate self-care, lifestylebased interventions, and CAM with conventional medicine through rational, comprehensive patient evaluation, and monitoring. This monitoring includes the use of biological measures to optimize function and guide IM recommendations. The rationale for IM approaches and the use of the healing model in cancer is that the heterogeneity of cancer, even in single patients, requires a multicomponent optimization of cellular and physiological function and the support of behavioral and lifestyle change even while disease-specific treatment is being delivered. IM approaches are thought to reduce side effects, increase completion of conventional therapy, improve quality of life, prolong survival, and empower patients in longterm prevention strategies. 11 An effective model for the scientific investigation of IM would be a breakthrough in cancer care and IM research in general and would lead to the development of integrated research teams for practice-based evaluation in health care. 12
Challenges to Research on IM
Challenges to obtaining data on IM were summarized in a White House Commission report and a recent Institute of Medicine (IOM) report on CAM and IM. 13, 14 These challenges include defining and developing standards of quality research; addressing the evolving nature of science with an increasing reliance on systems biology; the need to accommodate pluralism in research methods, especially those that have direct translational value; significant differences in underlying assumptions between biomedicine (cure focused) and CAM (healing focused) philosophies; and the need to explicitly manage social communication and knowledge exchange in multidisciplinary research teams. Because of these challenges, several attempts to evaluate CAM and IM in cancer have been prematurely stopped, wasting millions of dollars while providing no scientific advancement in the area. 15 Patients and health care practitioners need detailed and objective information integrated from diverse sources to successfully treat chronic disease. These challenges have been previously documented, [16] [17] [18] [19] [20] most recently in a response to the IOM. 21
Developing the Integrated Model for the Evaluation of Healing (IMEH)
The IMEH is an approach to the collection and integration of selected information from sociological, anthropological, and behavioral research and from cellular and molecular biology. It does this by developing a multidisciplinary team and approach to IM cancer care evaluation in several dimensions. The IMEH involves the integration of relevant variables in the following areas: (1) sociological, (2) psychological and behavioral, (3) clinical (diagnostic based), and (5) biological. These evaluation components are each developed by a specialized research team that feeds into an integrated data management, analysis, and modeling center for synthesis of the data. The data management component would operate across 3 key areas of functionality: data management, data integration, and data discovery. The IMEH data management center would leverage the benefits of structured data entry allowing researchers and clinicians using the system to input data into the data system using established data capture forms, which would then automatically encode and categorize the data according to common biomedical nomenclatures. The data would then be stored in a common repository. The data can then be queried, viewed, and analyzed independent of its origin.
Once captured and coded, data from disparate source repositories can be recombined in the patient record by the system. Using such data integration capabilities would allow IMEH team members to comprehensively study a subject's condition over time without having to query individual clinical information sources. Each record could accommodate a range of data formats, including multimedia content such as radiology and photographic images and genetic information, manually entered data like patient assessments, electronically captured data such as lab results, and structured data from clinical systems like billing information. Advanced text-processing tools will also enable the team to search and analyze doctor notes and other "free text" narratives from clinical records by automatically indexing this otherwise hard-to-access information. Such structured data can be further processed using artificial intelligence technology allowing for the possibility of real-time feedback of this information to the patient and health care team. This research approach allows for simultaneous structure-processoutcome evaluation including detailed observational and comparative data ready for translation into practice and a rich data set for hypothesis generation. It would collect and analyze its data using a web-based, distributed data management and analysis center that allows for customization, multicomponent and format input, bias shields, built-in quality checks, and rapid systems information analyses. Figure 1 illustrates organization of the process and the components of the multidisciplinary research teams.
The data collection methods for the IMEH are briefly described below:
1. The Rapid Ethnographic Team (RET) would collect data on the sociocultural aspects of IM and a connection practice. Data collected by the RET includes practice description and documentation, process evaluation, and details of the health encounter. This information ensures that we know what is actually done in IM practice. This team requires an expert in sociological/anthropological and ethnographic assessment of the medical encounter including CAM, as well as knowledge in qualitative research, process outcome measurement in health care, and integrative medicine delivery. 2. The Behavioral Assessment Team (BAT) would collect data on behaviors such as compliance and lifestyle change along with psychological and spiritual measures such as belief, expectancy, communication dynamics, and attitudes toward treatment. This team assesses utility and feasibility of the practice. This team requires a behavioral medicine researcher and expert in psychometrics.
The Clinical Outcomes and Health Services Team (CO/HS)
would collect conventional clinical measures on the condition and quality of life, quality of care, health status, adverse effects, utilization, and cost. This team requires an expert in clinical and health services research as well as an expert in cost-benefit measurement and analysis. 4. The Bioinformatics Team (BIT) would collect data on cellular and molecular measures such as genome and proteomic changes, tumor markers, inflammatory markers, apoptosis, cellular redox states, and progression measures for tracking objective biological information related to optimizing health function and adherence and for disease tracking. This section requires an expert in genomic and proteomics profiling and bioinformatics.
The Social and Conflict Knowledge Management Team
(SACKM) would monitor all the investigators and practitioners of the research team for communication issues. This aspect requires an expert in communication and social management and with experience in the application of these techniques in biomedical and IM research. 6. The Information, Data Management, and Analysis Center (IDMAC) would provide for integrated high throughput of data interface and complex systems analysis. This team requires an expert in data systems integration and bioinformatics for the analysis of complex nonlinear relationships. 22 Each of the above teams would be formed with expert consultants to develop the data collection and analysis procedures. A stepwise development process for the program would be employed that includes (1) framing the knowledge and social management process, (2) screening and selection of practices and research team members, (3) protocol development and assurances, (4) feasibility testing, (5) pilot testing, (6) hypothesis testing, and (7) data analysis development (see Figure 1 , right side). The development process will be iterative at each stage and include participation of IM expert practitioners and patient representatives in study development and execution. The goals of this process are to develop a relatively simple and practical battery of evaluation criteria and outcome measures for serial improvements in process, and outcome at each step. For application of the IMEH to integrative cancer care, the development team would select and compare standard cancer practices with IM assessing the outcomes of well-being, behavior, clinical outcomes, biomeasures, costs, and course in a population of prostate and breast cancer patients. On the clinical level, it would evaluate the effect of IM to mitigate toxicity and reduce side effects, manage weight, improve quality of life and energy, complete conventional therapy, and prolong survival. On the cellular and molecular levels, it would evaluate the ability of IM to reduce inflammatory processes and free-radical production and membrane oxidation, optimize glycemic control, bypass methylation defects, control autoimmunity, and support apoptosis. In addition, it would conduct comprehensive behavioral and compliance monitoring, including the assessment of feasibility and cost-benefit of IM.
In addition to providing an evaluation approach for complex clinical situations, it may be possible that the information collected in the IMEH approach could be streamlined, automated, and used in guiding clinical practice. This would be done by feeding IMEH data into an information management system for use in direct patient care. We call the latter (the information feedback process) the Health Avatar, and it would be a separate and practical application of the IMEH (see top oval of Figure 1 ).
Conclusion
The IMEH is an innovative proposal for whole systems research that addresses the major challenges in the scientific evaluation of healing-oriented IM practices in cancer care. The IMEH would also be an example of interdisciplinary investigation and "research teams of the future" called for under the NIH roadmap (http:// nihroadmap.nih.gov/researchteams/). The approach would require highly qualified investigators in each of the component areas described. We believe the IMEH could become a model for evaluation of whole systems of IM in chronic disease and cancer.
